Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,479 across all filing types
Latest filing 2021-04-02 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document title 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier' translates to 'Transactions in Coloplast shares by board members, directors, or closely related persons'. This is a standard notification for insider trading or director dealings. The document is very short and directs the reader to an attached PDF, which is characteristic of a notification filing.
2021-04-02 English
Director's Dealing 2021
Director's Dealing Classification · 1% confidence The document title explicitly states 'Trading in Coloplast shares by board members, executives or associated persons'. This directly corresponds to the definition of Director's Dealing (insider trades). Although the text is very short and points to an attachment, the specific subject matter overrides the general 'RPA' or 'RNS' fallback. The most precise classification is DIRS.
2021-04-02 English
Director's Dealing 2021
Director's Dealing Classification · 1% confidence The document explicitly details 'transactions of executives and their related parties in Coloplast shares and related securities' under the mandate of the Market Abuse Regulation article 19. It lists specific transactions involving share options exercise (purchase) and subsequent sale of shares by an Executive Vice President, including dates, prices, and volumes. This content directly corresponds to the reporting requirements for insider trading or executive share dealings, which maps precisely to the 'Director's Dealing' category (DIRS). It is not a general earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2021-04-02 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 12
Transaction in Own Shares Classification · 1% confidence The document is a weekly announcement from Coloplast detailing transactions made under their share buyback program. It lists specific dates, the number of shares purchased, average prices, and the total value of transactions for the week of March 22-26, 2021. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2021-03-29 Danish
Coloplast A/S - Transactions in connection with share buy-back programme, week 12
Transaction in Own Shares Classification · 1% confidence The document is a weekly update from Coloplast A/S regarding their share buyback program ('aktietilbagekøbsprogram'). It details the number of shares purchased, the average price, and the total transaction value for a specific week (week 12 of 2021). This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2021-03-29 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 12
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of Coloplast's share buy-back transactions for a specific week (week 12, 2021). It lists individual trade dates, volumes, prices, and venues, and explicitly references compliance with the EU Market Abuse Regulation (MAR) regarding share buy-back programs. This falls directly under the definition of 'Transaction in Own Shares' (POS).
2021-03-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.